Vasculogenic mimicry

APMIS

Volumn 112, Issue 7-8, 2004, Pages 508-525

  Folberg, Robert ^a,b   Maniotis, Andrew J ^a,b  

^a Department of Pathology ^*  (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Angiogenesis; Melanoma; Vasculogenesis; Vasculogenic mimicry

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CADHERIN; CD31 ANTIGEN; CD34 ANTIGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; COLLAGEN TYPE 6; ENDOSTATIN; FUMAGILLOL CHLOROACETYLCARBAMATE; GLYCOSAMINOGLYCAN; LAMININ; PLATELET DERIVED GROWTH FACTOR; PROSTATE SPECIFIC MEMBRANE ANTIGEN; PROTEIN S 100; PROTEOHEPARAN SULFATE; SCLEROPROTEIN; TISSUE FACTOR PATHWAY INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A;

ANGIOGENESIS; BREAST CARCINOMA; CANCER INVASION; CELL ULTRASTRUCTURE; EXTRACELLULAR MATRIX; HUMAN; MALIGNANT TRANSFORMATION; MELANOMA; NONHUMAN; OSTEOSARCOMA; OVARY CARCINOMA; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROSTATE CARCINOMA; REVIEW; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; SYNOVIAL SARCOMA; TUMOR CELL; UVEA MELANOMA; VASCULAR ENDOTHELIUM; VASCULOGENIC MIMICRY;

ANIMALS; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; HUMANS; MELANOMA; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; UVEAL NEOPLASMS;

EID: 10344236492     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2004.apm11207-0810.x     Document Type: Review

References (102)

1. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LMG, Pe'er J, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 1999;155:739-52.
2. Folberg R, Hendrix MJ, Maniotis AJ. Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 2000;156:361-81.
3. McDonald DM, Munn L, Jain RK. Vasculogenic mimicry: how convincing, how novel, and how significant? Am J Pathol 2000;156:383-8.
4. Singh AD and Topham A. Incidence of uveal melanoma in the United States: 1973-1997. Ophthalmology 2003;110:956-61.
5. McLean IW. The biology of haematogenous metastasis in human uveal malignant melanoma. Virchows Arch A Pathol Anat 1993;422:433-7.
6. Niederkorn JY. Immunoregulation of intraocular tumours. Eye 1997;11:249-54.
7. Clarijs R, Schalkwijk L, Ruiter DJ, de Waal RMW. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma. Invest Ophthalmol Vis Sci 2001;42:1422-8.
8. Folberg R, Rummelt V, Parys-Van Ginderdeuren R, Hwang T, Woolson RF, Pe'er J, et al. The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology 1993;100:1389-98.
9. Chen X, Maniotis AJ, Majumdar D, Pe'er J, Folberg R. Uveal melanoma cell staining for CD34 and assessment of tumor vascularity. Invest Ophthalmol Vis Sci 2002;43:2533-9.
10. Clarijs R, Otte-Holler I, Ruiter DJ, de Waal RM. Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma. Invest Ophthalmol Vis Sci 2002;43:912-8.
11. Hao XS, Sun BC, Zhang SW, Zhao XL. Correlation between the expression of collgen IV, VEGF and vasculogenic mimicry. Zhonghua Zhong Liu Za Zhi 2003;25:524-6.
12. Daniels KJ, Boldt HC, Martin JA, Gardner LM, Meyer M, Folberg R. Expression of Type VI collagen in uveal melanoma: role in pattern formation and tumor progression. Lab Invest 1996;75:55-66.
13. Potgens AJG, van Altena MC, Lubsen NH, Ruiter DJ, de Waal RMW. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor. Am J Pathol 1996;148:1203-17.
14. Smetsers TFCM, van de Westerlo EMA, ten Dam GB, Clarijs R, Versteeg, EMM, et al. Localization and characterization of melanoma-associated glycosaminoglycans: Differential expression of chondroitin and heparan sulfate epitopes in melanoma. Cancer Res 2003;63:2965-70.
15. Rummelt V, Mehaffey MG, Campbell RJ, Peer J, Bentler SE, Woolson RF, et al. Microcirculation architecture of metastases from primary ciliary body and choroidal melanomas. Am J Ophthalmol 1998;126:303-5.
16. Sakamoto T, Sakamoto M, Yoshikawa H, Hata Y, Ishibashi T, Ohnishi Y, et al. Histologic findings and prognosis of uveal malignant melanoma in Japanese patients. Am J Ophthalmol 1996;121:26-83.
17. Schaling DF, van der Pol JP, Schlingemann RO, Parys-Van Ginderdeuren R, Jager MJ. Vascular density and vascular patterns in the prognosis of choroidal melanoma. Thesis. Rijksuniversteit te Leiden. 1996:43-54.
18. McLean IW, Keefe KS, Burnier MN. Uveal melanoma: comparison of the prognostic value of fibrovascular loops, mean of the ten largest nucleoli, cell type and tumor size. Ophthalmology 1997;104:777-80.
19. Seregard S, Spangberg B, Juul C, Oskarsson M. Prognostic accuacy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma. Ophthalmology 1998;105:485-91.
20. Makitie T, Summanen P, Tarkannen A, Kivela T. Microvascular loops and networks as prognostic indicators in choroidal and ciliary body melanomas. J Nat Cancer Inst 1999;91:359-67.
21. Folberg R, Fleck M, Mehaffey MG, Meyer M, Bentler SE, Woolson RF, et al. Mapping prognostically significant vascular patterns in ciliary body and choroidal melanomas. Pathol Oncol Res 1996;2:229-36.
22. Mehaffey MG, Folberg R, Meyer M, Bentler SE, Hwang T, Woolson RF, et al. Relative importance of quantifying area and vascular patterns in uveal melanoma. Am J Ophthalmol 1997;123:798-809.
23. Coleman DJ, Rondeau MJ, Silverman RH, Folberg R, Rummelt V, Woods SM, et al. Correlation of microcirculation architecture with ultrasound parameters of uveal melanoma. Eur J Ophthalmol 1995;5:96-106.
24. Silverman RH, Folberg R, Boldt HC, Rondeau MJ, Lloyd HO, Mehaffey MG, et al. Correlation of ultrasound parameter imaging with microcirculatory patterns in uveal melanomas. Ultrasound Med Biol 1997;23:573-81.
25. Silverman RH, Lizzi FL, Ursea BG, Cozzarelli L, Ketterling JA, Deng CX, et al. Safety levels for exposure of cornea and lens to very high-frequency ultrasound. J Ultrasound Med 2001;20:979-86.
26. Silverman RH, Folberg R, Rondeau MJ, Boldt HC, Lloyd HO, Chen X, et al. Spectral parameter imaging for detection of prognostically significant histologic features in uveal melanoma. Ultrasound Med Biol 2003;29:951-9.
27. Coleman DJ, Silverman MJ, Boldt HC, Lloyd HO, Lizzi FL, Weingeist TA, et al. Noninvasive in vivo detection of prognostic indicators for high-risk uveal melanoma - Ultrasound parameter Imaging. Ophthalmology 2004;111:558-64.
28. Thies A, Mangold U, Moll I, Schumacher U. PAS-positive loops and networks as a prognostic indicator in cutaneous malignant melanoma. J Pathol 2001;195:537-42.
29. Warso MA, Maniotis AJ, Chen X, Majumdar D, Patel MK, Shilkaitis A, et al. Prognostic significance of periodic acid-Schiff-positive patterns in primary cutaneous melanoma. Clin Cancer Res 2001;7:473-7.
30. Sun BC, Zhang SW, Zhao XL, Hao XS. Study on vasculogenic mimicry in malignant melanoma. Zhonghua Bing Li Xue Za Zhi 2003;32:539-43.
31. Massi D, Franchi A, Paglierani M, Ketabchi S, Borgognoni L, Reali UM, et al. Vasculogenic mimicry has no prognostic significance in pT3 and pT4 cutaneous melanoma. Hum Pathol 2004;35:496-502.
32. Lee YJ, Nagai N, Siar CH, Nakano K, Nagatsuka H, Tsujigiwa H, et al. Angioarchitecture of primary oral malignant melanomas. J Histochem Cytochem 2002;50:1555-62.
33. Shirakawa K, Tsuda H, Heike Y, Kato K, Asada R, Inomata M, et al. Absence of endothelial cells, central necrosis, and fibrosis are associated with aggressive inflammatory breast cancer. Cancer Res 2001;61:445-51.
34. Shirakawa K, Kobayashi H, Heike Y, Kawamoto S, Brechbiel MW, Kasumi, et al. Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft. Cancer Res 2002;62:560-6.
35. Shirakawa K, Wakasugi H, Heike Y, Watanabe I, Yamada S, Saito K, et al. Vasculogenic mimicry and pseudo-comedo formation in breast cancer. Int J Cancer 2002;99:821-8.
36. Shirakawa K, Furuhata S, Watanabe I, Hayase H, Shimizu A, Ikarashi Y, et al. Induction of vasculogenesis in breast cancer models. Br J Cancer 2002;87:1454-61.
37. Shirakawa K, Kobayashi H, Sobajima J, Hashimoto D, Shimizu A, Wakasugi H. Inflammatory breast cancer: vasculogenic mimicry and its hemodynamics of an inflammatory breast cancer xenograft model. Breast Cancer Res 2003;5:136-9.
38. Buijs JT, Cleton AM, Smit VT, Lowik CW, Papapoulos E, Pluijm G. Prognostic significance of periodic acid-Schiff-positive patterns in primary breast cancer and its lymph node metastases. Breast Cancer Res Treat 2004;84:117-30.
39. Sharma N, Seftor RE, Seftor EA, Gruman LM, Heidger PM Jr, Cohen MB, et al. Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry. Prostate 2002;50:189-201.
40. Sood AK, Seftor EA, Fletcher MS, Gardner LMG, Heidger PM, Buller RE, et al. Molecular determinants of ovarian cancer plasticity. Am J Pathol 2001;158:1279-88.
41. Hao X, Sun B, Zhang S, Zhao X. Microarray study of vasculogenic mimicry in bi-directional differentiation malignant tumor. Zhonghua Yi Xue Za Zhi 2002;82:1298-302.
42. Favier J, Plouin PF, Corvol P, Gasc JM. Angiogenesis and vascular architecture in pheochromocytomas - Distinctive traits in malignant tumors. Am J Pathol 2002;161:1235-46.
43. Potter CJ, Turenchalk GS, Xu T. Drosophila in cancer research. An expanding role. Trends Genet 2000;16:33-9.
44. Folberg R, Mehaffey M, Gardner LM, Meyer M, Rummelt V, Pe'er J. The microcirculation of choroidal and ciliary body melanomas. Eye 1997;11:227-38.
45. Chen X, Ai Z, Rasmussen M, Bajcsy P, Auvil L, Welge M, et al. Three-dimensional reconstruction of extravascular matrix patterns and blood vessels in human uveal melanoma tissue: techniques and preliminary findings. Invest Ophthalmol Vis Sci 2003;44:2834-40.
46. Folberg R, Pe'er J, Gruman LM, Woolson RF, Jeng G, Montague PR, et al. The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study. Hum Pathol 1992;23:1298-305.
47. Maniotis AJ, Chen X, Garcia C, DeChristopher PJ, Wu D, Pe'er J, et al. Control of melanoma morphogenesis, endothelial survival, and perfusion by extracellular matrix. Lab Invest 2002;82:1031-43.
48. Seftor EA, Meltzer PS, Kirschmann DA, Pe'er J, Maniotis AJ, Trent JM, et al. Molecular determinants of human uveal melanoma invasion and metastasis. Clin Exp Met 2002;19:233-46.
49. Folberg R, Chen X, Boldt HC, Pe'er J, Brown CK, Woolson RF, et al. Microcirculation patterns other than loops and networks in choroidal and ciliary body melanomas. Ophthalmology 2001;108:996-1001.
50. Schaling DF, Oosterhuis JA, Jager MJ, Kakebeeke-Kemme H, Pauwels EKJ. Possibilities and limitations of radioimmunoscintigraphy and conventional diagnostic modalities in choroidal melanoma. Br J Ophthalmol 1994;78:244-8.
51. Loeffler KU and McLean IW. Membrane patterns, Factor VIII staining and prognosis in 100 cases of human uveal melanoma. Invest Ophthalmol Vis Sci 2001;42(suppl):S216.
52. Jensen OA. Malignant melanoma of the choroid of a peculiar cavernous type: clinical manifestation by hemorrhage of the vitreous body. Arch Ophthalmol 1964;72:337-40.
53. Radnot M and Antal M. Vessels of intraocular malignant melanomas. Am J Ophthalmol 1979;88:472-8.
54. Timar J and Toth J. Tumor sinuses - vascular channels. Pathol Oncol Res 2000;6:83-6.
55. Konerding MA, Steinberg F, Budach V. The vascular system of xenotransplanted tumors-scanning electron and light microscopic studies. Scanning Microsc 1989;3:327-35.
56. Konerding MA, Steinberg F, Streffer C. The vasculature of xenotransplanted human melanomas and sarcomas on nude mice. Acta Anat 1989;136:21-6.
57. Hammersen F, Endrich B, Messmer K. The fine structure of tumor blood vessels. I. Participation of non- endothelial cells in tumor angiogenesis. Int J Microcirc Clin Exp 1985;4:31-43.
58. Chang YS, di Tomaso E, McDonald DM, Jones R, Jain RK, Munn LL. Mosaic blood vessels in tumor: frequency of cancer cells in contact with flowing blood. Proc Nat Acad Sci USA 2000;97:14608-13.
59. Folkman J. Can mosaic tumor vessels facilitate molecular diagnosis of cancer? Proc Nat Acad Sci USA 2001;98:398-400.
60. Warren BA and Shubik P. The growth of the blood supply to melanoma transplants in the hamster cheek pouch. Lab Invest 1966;15:464-78.
61. Ruf W, Seftor EA, Petrovan RJ, Weiss RM, Gruman LM, Margaryan NV, et al. Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry. Cancer Res 2003;63:5381-9.
62. Nasu R, Kimura H, Akagi K, Murata T, Tanaka Y. Blood flow influences vascular growth during tumour angiogenesis. Br J Cancer 1999;79:780-6.
63. Shubik P and Warren BA. Additional literature on "vasculogenic mimicry" not cited. Am J Pathol 2000;156:736.
64. McDonald DM and Foss AJE. Endothelial cells of tumor vessels: Abnormal but not absent. Cancer Met Rev 2000;19:109-20.
65. Liu C, Huang H, Donate F, Dickinson C, Santucci R, El Sheikh A, et al. Prostate-specific membrane antigen directed selective thrombotic infarction of tumors. Cancer Res 2002;62:5470-5.
66. Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M, et al. Molecular classification of cutaneous melanoma by gene expression profiling. Nature 2000;406:536-40.
67. Seftor EA, Meltzer PS, Kirschmann DA, Pe'er J, Maniotis AJ, Trent JM, et al. Molecular determinants of uveal melanoma metastasis. Clin Exp Met 2002;19:233-46.
68. Zhou Y, Fisher SJ, Janatpour M, Genbacev O, Dejana E, Wheelock M, et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 1997;99:2139-51.
69. Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest 1997;99:2152-64.
70. Damsky CH and Fisher SJ. Trophoblast pseudovasculogenesis: faking it with endothelial adhesion receptors. Cur Opinion Cell Biol 1998;10:660-6.
71. Hendrix MJ, Seftor RE, Seftor EA, Gruman LM, Lee LM, Nickoloff BJ, et al. Transendothelial function of human metastatic melanoma cells: role of the microenvironment in cell-fate determination. Cancer Res 2002;62:665-8.
72. Sood AK, Fletcher MS, Hendrix MJ. The embryonic-like properties of aggressive human tumor cells. J Soc Gynecol Investig 2002;9:2-9.
73. Hendrix MJC, Seftor EA, Hess AR, Seftor REB. Molecular plasticity of human melanoma cells. Oncogene 2003;22:3070-5.
74. Takahashi H, Strutton GM, Parsons PG. Determination of proliferating fractions in malignant melanomas by anti-PCNA/cyclin monoclonal antibody. Histopathol 1991;18:221-7.
75. Hughes SE. Functional characterization of the spontaneously transformed human umbilical vein endothelial cell line ECV304: use in an in vitro model of angiogenesis. Exp Cell Res 1996;225:171-85.
76. Lucas M, Rose PE, Morris AG. Contrasting effects of HSP72 expression on apoptosis in human umbilical vein endothelial cells and an angiogenic cell line, ECV304. Br J Haematol 2000;110:957-64.
77. Hendrix MJ, Seftor EA, Meltzer PS, Gardner LM, Hess AR, Kirschmann DA, et al. Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc Natl Acad Sci U S A 2001;98:8018-23.
78. LaPorta CA, De Biasi S, Rao S, Fascio U, Mihm MC, Clemente C. Molecular mechanism of vasculogenic mimicry. Proc Am Assoc Cancer Res 2004;45.
79. Hendrix MJC, Seftor EA, Hess AR, Seftor REB. Vasculogenic mimicry and tumour-cell plasticity: Lessons from melanoma [Review]. Nat Cancer 2003;3:411-21.
80. Baron JA, Monzon F, Galaria N, Murphy GF. Angiomatoid melanoma: A novel pattern of differentiation in invasive periocular desmoplastic malignant melanoma. Hum Pathol 2000;31:1520-2.
81. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 2000;156:1363-80.
82. Weidner N. Tumoral vascularity as a prognostic factor in cancer patients - the evidence continues to grow. J Pathol 1998;184:119-22.
83. Foss AJE, Alexander RA, Hungerford JL, Harris AL, Cree IA, Lightman S. Re-assessment of the PAS patterns in uveal melanoma. Br J Ophthalmol 1997;81:240-6.
84. Makitie T, Summanen P, Tarkkanen A, Kivela T. Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma. Invest Ophthalmol Vis Sci 1999;40:2471-80.
85. Hlatky L, Hahnfeldt P, Folkman J. Clinical Application of Antiangiogenic Therapy: Microvessel Density, What It Does and Doesn't Tell Us. J Natl Cancer Inst 2002;94:883-93.
86. Kobayashi H, Shirakawa K, Kawamoto S, Saga T, Sato N, Hiraga A, et al. Rapid accumulation and internalization of radiolabeled herceptin in an inflammatory breast cancer xenograft with vasculogenic mimicry predicted by the contrast-enhanced dynamic MRI with the macromolecular contrast agent G6-(1B4M-Gd)256). Cancer Res 2002;62:860-6.
87. Mueller AJ, Bartsch DU, Folberg R, Mehaffey MG, Boldt HC, Meyer M, et al. Imaging the microvasculature of choroidal melanomas with confocal indocyanine green scanning laser ophthalmoscopy. Arch Ophthalmol 1998;116:31-9.
88. Mueller AJ, Freeman WR, Folberg R, Bartsch DU, Scheider A, Schaller, et al. Evaluation of microvascularization pattern visibility in human choroidal melanomas: comparison of confocal fluorescein with indocyanine green angiography. Graefes Arch Clin Exp Ophthalmol 1999;237:448-56.
89. Mueller AJ, Schaller U, Freeman W, Folberg R, Kampik A. Complex microcirculation patterns detected by confocal Indocyanine green angiography predict time to growth of small choroidal melanocytic tumors. MuSIC-Report II. Ophthalmology 2002;109:2207-14.
90. Nagy JA, Brown LF, Senger DR, Lanir N, Van De WL, Dvorak AM, et al. Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta 1989;948:305-26.
91. Folberg R, Chen X, Boldt HC, Pe'er J, Brown CK, Woolson RF, et al. Microcirculation patterns other than loops and networks in choroidal and ciliary body melanomas. Ophthalmology 2000;108:996-1001.
92. Kivela T, Makitie T, Al Jamal RT, Toivonen P. Microvascular loops and networks in uveal melanoma. Can J Ophthalmol 2004.
93. Foss AJE, Alexander RA, Jefferies LW, Hungerford JL, Harris AL, Lightman S. Microvessel count predicts survival in uveal melanoma. Cancer Res 1996;56:2900-3.
94. Clarijs R, Ruiter DJ, de Waal RMW. Pathophysiological implications of stroma pattern formation in uveal melanoma. J Cell Physiol 2003;194:267-71.
95. van Kempen LCLT, Ruiter DJ, van Muijen GNP, Coussens LM. The tumor microenvironment: a critical determinant of neoplastic evolution [Review]. Eur J Cell Biol 2003;82:539-48.
96. Ruiter D, Bogenrieder T, Elder D, Herlyn M. Melanoma-stroma interactions: structural and functional aspects. Lancet Oncol 2002;3:35-43.
97. Seftor REB, Seftor EA, Koshikawa N, Meltzer PS, Gardner LMG, Bilban M, et al. Cooperative interactions of laminin 5 {gamma} 2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are reFLYOVERquired for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res 2001;61:6322-7.
98. Cai XS, Jia YW, Mei J, Tang RY. Tumor blood vessels formation in osteosarcoma: vasculogenesis mimicry. Chin Med J (Engl) 2004;117:94-8.
99. Rummelt V, Folberg R, Rummelt C, Gruman LM, Hwang T, Woolson RF, et al. Microcirculation architecture of melanocytic nevi and malignant melanomas of the ciliary body and choroid. A comparative histopathologic and ultrastructural study. Ophthalmology 1994;101:718-27.
100. Pezzella F, Pastorino U, Tagliabue E, Andreola S, Sozzi G, Gasparini G, et al. Non small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol 1997;151:1417-23.
101. Passalidou E, Trivella M, Singh N, Ferguson M, Hu J, Cesario A, et al. Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas. Br J Cancer 2002;86:244-9.
102. Sanz L, Feijoo M, Blanco B, Serrano A, Alvarez-Vallina L. Generation of non-permissive basement membranes by anti-laminin antibody fragments produced by matrix-embedded gene-modified cells. Cancer Immunol Immunother 2003;52:643-7.